Cell & Tissue Preservation Market Forecast Report, 2021-2031

Cell & Tissue Preservation Market (Type: Cells and Tissues; Application: Therapeutics, Research & Development, Drug Discovery, and Others; Product: Equipment, Bio Preservation Media, and Software; and End User: Biobanks, Hospitals, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Implementation of Risk-mitigation Strategies at Fertility Centers amidst COVID-19 Pandemic

The reopening of fertility care services in the midst of the COVID-19 pandemic lead to numerous concerns that need immediate addressing. Companies in the cell & tissue preservation market are gaining awareness about these concerns to prevent the risk of cross-contamination and transmission at the fertility centers. Due to the novelty of the disease, there is a need for more information confirming an association of coronavirus with reproductive tissues, embryos, and gametes.

Cryobanking, being an essential service in fertility preservation, is linked with the risk of cross-contamination through the cryogenic mediums. Stakeholders are increasing research to find possible sources of cross-contamination through liquid nitrogen.

cell & tissue preservation market infographic

Request a sample to get extensive insights into the Cell & Tissue Preservation Market

Ice-related Damage in Tissues Creates Drawbacks in Cryopreservation

Cryopreservation holds potential to strongly benefit several areas of medicine by increasing the ease with which therapeutic cells, tissues, and organs can be stored. However, it has been found that extracellular ice directly damages tissues, either by puncturing or crushing cell membranes or by disrupting extracellular structures. In order to reduce the extent of ice-related damage, stakeholders are making use of cryopreservation protocols such as the CPAs (cryoprotective agents).

CPAs help to reduce the concentration of electrolytes and ice formation by hydrogen bonding with water molecules to prevent them from bonding to ice crystals. CPAs capable of crossing cell membranes are crucial in cryopreservation. The use of such molecules, termed penetrating CPAs (pCPAs), can substantially reduce cryoinjury.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Application of Oxygen in Preservation of Transplant Organs Gains Popularity

The cell & tissue preservation market is projected to grow at a robust CAGR of 11.9% from 2021 to 2031. Giner Life Sciences - a privately-held company focused on the development and commercialization of oxygenated cell therapies, is pursuing new approaches in the application of oxygen for the preservation of transplant organs and clusters of cells inside implantable capsules. Companies in the cell & tissue preservation market are taking cues from such innovative approaches to develop transportation devices for a donated pancreas organ, which incorporates an on-demand oxygen generator.

Transportation device incorporating an on-demand oxygen generator holds potential to supply oxygen to the vasculature of the pancreas as soon as possible after it is donated.

Toxicity of DMSO Leads to Innovations in Biomimetic Materials

There is a need for mid-range automation for cryopreservation. Companies in the cell & tissue preservation market are innovating in robot in order to meet this demand. Though dimethyl sulfoxide (DMSO) is considered as the gold standard for cryopreservation of mammalian cells and tissues, certain concentrations of DMSO can be toxic to cells. Thus, to mitigate potential toxicity problems, companies in the cell & tissue preservation market are increasing research on using different combinations of cryoprotective agents such as supplementing a lower concentration of DMSO with the glycerol or polypropylene glycol.

Moreover, companies are increasing efforts to introduce alternatives to DMSO such as biomimetic materials that are called the antifreeze protein or an ice-binding protein.

cell & tissue preservation market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Cell & Tissue Preservation Market

Analysts’ Viewpoint

Companies in the cell & tissue preservation market are adopting strategies to reduce the risks of cross-contamination at fertility centers, especially for oncofertility, amid the COVID-19 pandemic.. The cell & tissue preservation market is expected to reach US$ 10.04 Bn by 2031. However, one of the main limitations of current cryopreservation methods is the recovery rate of cells after freezing. Hence, companies should increase research in antifreeze proteins that have the potential to mimic the properties of synthetic polymers in cryopreservation methods. In addition, transportation devices incorporating on-demand oxygen generator are being publicized for use in organ transplant applications.

Cell & Tissue Preservation Market: Overview

  • Cell & tissue banks are biorepositories for the preservation of human and animal cells & tissues utilized for biodiversity studies, disease diagnosis, and research. These banks assist in the storage of various types of tissue samples such as bone, skin, cornea, heart valves, umbilical cord, and human soft tissues.
  • Cell & tissue banks vary significantly in size, with cell & tissue banks in medical institutions storing a moderate number of samples, while national tissue banks store a large number of samples. These samples are utilized to support research, particularly studies in personalized medicine, genetic disorders, and stem cell research to treat genetic conditions and maintain and update age demographic databases.
  • Increasing demand for regenerative medicines is a significant factor driving the global cell & tissue preservation market. These medicines are capable of replacing, engineering, and regenerating functional cells, tissues for treating tissue loss due to age-related diseases or conditions, diseases, major injury, or congenital defects.
  • Other vital factors driving the market include increasing prevalence of cardiovascular and neurological disorders, a variety of cancers, diabetes, and other diseases
  • Increasing need for storage of organs for transplant and research of new patient medicines in research center initiatives by healthcare organizations to improvise healthcare facilities are anticipated to fuel the global cell & tissue preservation market

Market Segmentation: Cell & Tissue Preservation Market

  • In terms of type, the global cell & tissue preservation market has been classified into cells and tissues. Cells have been split into mammalian cells & others (microorganisms and plant cells). The tissues segment has been categorized into blood, bone, soft tissues, skin, and others. Rise in investments in the field of regenerative medicine research is estimated to propel the market. Human blood, tissues, cells, and organs own the capability to heal damaged tissues and organs with long-term advantages.
  • Based on application, the global cell & tissue preservation market has been divided into therapeutics, research & development, drug discovery, and others. Tissues preserved in tissue banks could be utilized to fulfill a variety of medical needs of people. For instance, heart valves can be used in patients with heart disorders; corneal transplantation can be used to provide vision to blind people; tendons and ligaments can be used in orthopedic surgery; and blood can be employed to treat blood disorders.
  • In terms of product, the global cell & tissue preservation market has been divided into equipment, bio preservation media, and software. The equipment segment has been further sub-segmented into freezers, thawing equipment, refrigerators, storage systems, and others. While the bio preservation media segment has been further classified into home-brew media and pre-formulated media. In terms of equipment type, the cryopreservation systems segment dominated the market in 2020. Cryopreservation is the process of cooling followed by storage of frozen cells to provide a continuous supply of genetically stable living cells by inhibiting all biochemical activities that are to be used for procedures such as organ donation, bone marrow transplant, and others.
  • Based on end user, the global cell & tissue preservation market has been segmented into biobanks, hospitals, and others. Biobanks store numerous different types of biospecimens, ranging from cells and small tissue samples right through to whole organs, whole limbs, or even whole bodies. Cells and small biospecimens could be flash frozen in cryoprotectant solutions and stored in liquid nitrogen to preserve their structure and function.
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The cell & tissue preservation market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031, along with market size estimations.

Regional Overview: Cell & Tissue Preservation Market

  • In terms of region, the global cell & tissue preservation market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • The current and expected market value (US$ Mn) of these regional markets and their major countries have been provided in the report from 2021 to 2031, with their CAGRs from 2021 to 2031
  • The study also offers a list of recommendations, highlights, and useful insights of the global cell & tissue preservation market, which would help new companies willing to enter the market and existing companies to increase market shares and in the decision-making process

Major Players

  • The cell & tissue preservation market report concludes with the company profiles section, which includes key information about major players in the global cell & tissue preservation market
  • Leading players analyzed in the report include
    • Thermo Fisher Scientific, Inc.
    • Lonza
    • BD
    • Merck KGaA
    • Cytiva
    • Agilent Technologies, Inc.
    • Avantor, Inc.
    • FUJIFILM Irvine Scientific
    • BioLifeSolutions Inc.
    • AMSBIO
    • Princeton CryoTech
    • STEMCELL Technologies Inc.
    • LGC SeraCare
    • Corning Incorporated
    • CellGenix GmbH
  • Each of these players has been profiled in the cell & tissue preservation market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Cell & Tissue Preservation Market – Segmentation

TMR’s study on the global cell & tissue preservation market includes information divided into five segments: type, application, product, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global cell & tissue preservation market are discussed in detail.

Type
  • Cells
    • Mammalian Cells
    • Others (Microorganisms and Plant Cells)
  • Tissues
    • Blood
    • Bone
    • Soft Tissues
    • Skin
    • Others
Product
  • Software
  • Equipment
    • Freezers
    • Refrigerators
    • Storage Systems
    • Others
  • Bio Preservation Media
    • Home-brew Media
    • Pre-formulated Media
End User
  • Biobanks
  • Hospitals
  • Others
Application
  • Therapeutics
  • Research & Development
  • Drug Discovery
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of cell & tissue preservation market?

Cell & tissue preservation market to reach valuation Of US$ 10.04 Bn by 2031

What is the anticipated CAGR of the cell & tissue preservation market in the forecast period?

Cell & tissue preservation market is projected to grow at a robust CAGR of 11.9% from 2021 to 2031

What are the key driving factors for the growth of the cell & tissue preservation market?

Cell & tissue preservation market is driven by increasing demand for regenerative medicines

What are the end-use segments in the cell & tissue preservation market?

The end-use segments in cell & tissue preservation market are biobanks, hospitals & others

Who are the key players in the global cell & tissue preservation market?

Key players operating in the global cell & tissue market include Thermo Fisher Scientific, Inc., Lonza, BD, Merck KGaA, Cytiva, Agilent Technologies, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Cell & Tissue Preservation Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Cell & Tissue Preservation Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)

        5.2. COVID-19 Pandemic Impact on Industry (value chain and short-/ mid-/ long-term impact)

        5.3. Process Analysis

        5.4. Top companies operating in Market Space

        5.5. Applications of cell & tissue culture in drug development

        5.6. Technological Advancements

    6. Global Cell & Tissue Preservation Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Global Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

            6.3.1. Cells

                6.3.1.1. Mammalian Cells

                6.3.1.2. Others (microorganisms and plant cells)

            6.3.2. Tissues

                6.3.2.1. Blood

                6.3.2.2. Bone

                6.3.2.3. Soft Tissues

                6.3.2.4. Skin

                6.3.2.5. Others

        6.4. Global Cell & Tissue Preservation Market Attractiveness, by Type

    7. Global Cell & Tissue Preservation Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Global Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

            7.3.1. Therapeutics

            7.3.2. Research & Development

            7.3.3. Drug Discovery

            7.3.4. Others (Cosmetics and Clinical trials)

        7.4. Global Cell & Tissue Preservation Market Attractiveness, by Application

    8. Global Cell & Tissue Preservation Market Analysis and Forecast, by Product

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Global Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

            8.3.1. Equipment

                8.3.1.1. Freezers

                8.3.1.2. Thawing Equipment

                8.3.1.3. Refrigerators

                8.3.1.4. Storage Systems

                8.3.1.5. Others

            8.3.2. Bio preservation media

                8.3.2.1. Home-brew media

                8.3.2.2. Pre-formulated media

            8.3.3. Software

        8.4. Global Cell & Tissue Preservation Market Attractiveness, by Product

    9. Global Cell & Tissue Preservation Market Analysis and Forecast, by End-user

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Global Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

            9.3.1. Biobanks

            9.3.2. Hospitals

            9.3.3. Others

        9.4. Global Cell & Tissue Preservation Market Attractiveness, by End-user

    10. Global Cell & Tissue Preservation Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Global Cell & Tissue Preservation Market Value Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Global Cell & Tissue Preservation Market Attractiveness, by Region

    11. North America Cell & Tissue Preservation Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. North America Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

            11.2.1. Cells

                11.2.1.1. Mammalian Cells

                11.2.1.2. Others (microorganisms and plant cells)

            11.2.2. Tissues

                11.2.2.1. Blood

                11.2.2.2. Bone

                11.2.2.3. Soft Tissues

                11.2.2.4. Skin

                11.2.2.5. Others

        11.3. North America Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

            11.3.1. Therapeutics

            11.3.2. Research & Development

            11.3.3. Drug Discovery

            11.3.4. Others (Cosmetics and Clinical trials)

        11.4. North America Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

            11.4.1. Equipment

                11.4.1.1. Freezers

                11.4.1.2. Thawing Equipment

                11.4.1.3. Refrigerators

                11.4.1.4. Storage Systems

                11.4.1.5. Others

            11.4.2. Bio preservation media

                11.4.2.1. Home-brew media

                11.4.2.2. Pre-formulated media

            11.4.3. Software

        11.5. North America Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

            11.5.1. Biobanks

            11.5.2. Hospitals

            11.5.3. Others

        11.6. North America Cell & Tissue Preservation Market Value Forecast, by Country, 2017–2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. North America Cell & Tissue Preservation Market Attractiveness Analysis

            11.7.1. By Type

            11.7.2. By Application

            11.7.3. By Product

            11.7.4. By End-user

            11.7.5. By Country

    12. Europe Cell & Tissue Preservation Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Europe Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

            12.2.1. Cells

                12.2.1.1. Mammalian Cells

                12.2.1.2. Others (microorganisms and plant cells)

            12.2.2. Tissues

                12.2.2.1. Blood

                12.2.2.2. Bone

                12.2.2.3. Soft Tissues

                12.2.2.4. Skin

                12.2.2.5. Others

        12.3. Europe Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

            12.3.1. Therapeutics

            12.3.2. Research & Development

            12.3.3. Drug Discovery

            12.3.4. Others (Cosmetics and Clinical trials)

        12.4. Europe Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

            12.4.1. Equipment

                12.4.1.1. Freezers

                12.4.1.2. Thawing Equipment

                12.4.1.3. Refrigerators

                12.4.1.4. Storage Systems

                12.4.1.5. Others

            12.4.2. Bio preservation media

                12.4.2.1. Home-brew media

                12.4.2.2. Pre-formulated media

            12.4.3. Software

        12.5. Europe Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

            12.5.1. Biobanks

            12.5.2. Hospitals

            12.5.3. Others

        12.6. Europe Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Europe Cell & Tissue Preservation Market Attractiveness Analysis

            12.7.1. By Type

            12.7.2. By Application

            12.7.3. By Product

            12.7.4. By End-user

            12.7.5. By Country/Sub-region

    13. Asia Pacific Cell & Tissue Preservation Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

            13.2.1. Cells

                13.2.1.1. Mammalian Cells

                13.2.1.2. Others (microorganisms and plant cells)

            13.2.2. Tissues

                13.2.2.1. Blood

                13.2.2.2. Bone

                13.2.2.3. Soft Tissues

                13.2.2.4. Skin

                13.2.2.5. Others

        13.3. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

            13.3.1. Therapeutics

            13.3.2. Research & Development

            13.3.3. Drug Discovery

            13.3.4. Others (Cosmetics and Clinical trials)

        13.4. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

            13.4.1. Equipment

                13.4.1.1. Freezers

                13.4.1.2. Thawing Equipment

                13.4.1.3. Refrigerators

                13.4.1.4. Storage Systems

                13.4.1.5. Others

            13.4.2. Bio preservation media

                13.4.2.1. Home-brew media

                13.4.2.2. Pre-formulated media

            13.4.3. Software

        13.5. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

            13.5.1. Biobanks

            13.5.2. Hospitals

            13.5.3. Others

        13.6. Asia Pacific Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis

            13.7.1. By Type

            13.7.2. By Application

            13.7.3. By Product

            13.7.4. By End-user

            13.7.5. By Country/Sub-region

    14. Latin America Cell & Tissue Preservation Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Latin America Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

            14.2.1. Cells

                14.2.1.1. Mammalian Cells

                14.2.1.2. Others (microorganisms and plant cells)

            14.2.2. Tissues

                14.2.2.1. Blood

                14.2.2.2. Bone

                14.2.2.3. Soft Tissues

                14.2.2.4. Skin

                14.2.2.5. Others

        14.3. Latin America Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

            14.3.1. Therapeutics

            14.3.2. Research & Development

            14.3.3. Drug Discovery

            14.3.4. Others (Cosmetics and Clinical trials)

        14.4. Latin America Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

            14.4.1. Equipment

                14.4.1.1. Freezers

                14.4.1.2. Thawing Equipment

                14.4.1.3. Refrigerators

                14.4.1.4. Storage Systems

                14.4.1.5. Others

            14.4.2. Bio preservation media

                14.4.2.1. Home-brew media

                14.4.2.2. Pre-formulated media

            14.4.3. Software

        14.5. Latin America Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

            14.5.1. Biobanks

            14.5.2. Hospitals

            14.5.3. Others

        14.6. Latin America Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Market Attractiveness Analysis

            14.7.1. By Type

            14.7.2. By Application

            14.7.3. By Product

            14.7.4. By End-user

            14.7.5. By Country

    15. Middle East & Africa Cell & Tissue Preservation Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Type, 2017–2031

            15.2.1. Cells

                15.2.1.1. Mammalian Cells

                15.2.1.2. Others (microorganisms and plant cells)

            15.2.2. Tissues

                15.2.2.1. Blood

                15.2.2.2. Bone

                15.2.2.3. Soft Tissues

                15.2.2.4. Skin

                15.2.2.5. Others

        15.3. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Application, 2017–2031

            15.3.1. Therapeutics

            15.3.2. Research & Development

            15.3.3. Drug Discovery

            15.3.4. Others (Cosmetics and Clinical trials)

        15.4. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Product, 2017–2031

            15.4.1. Equipment

                15.4.1.1. Freezers

                15.4.1.2. Thawing Equipment

                15.4.1.3. Refrigerators

                15.4.1.4. Storage Systems

                15.4.1.5. Others

            15.4.2. Bio preservation media

                15.4.2.1. Home-brew media

                15.4.2.2. Pre-formulated media

            15.4.3. Software

        15.5. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by End-user, 2017–2031

            15.5.1. Biobanks

            15.5.2. Hospitals

            15.5.3. Others

        15.6. Middle East & Africa Cell & Tissue Preservation Market Value Forecast, by Country/Sub-region, 2017–2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis

            15.7.1. By Type

            15.7.2. By Application

            15.7.3. By Product

            15.7.4. By End-user

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Share Analysis, by Company (2019)

        16.2. Company Profiles

            16.2.1. Thermo Fisher Scientific, Inc.

                16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.1.2. Product Portfolio

                16.2.1.3. SWOT Analysis

                16.2.1.4. Strategic Overview

            16.2.2. Lonza

                16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.2.2. Product Portfolio

                16.2.2.3. SWOT Analysis

                16.2.2.4. Strategic Overview

            16.2.3. BD

                16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.3.2. Product Portfolio

                16.2.3.3. SWOT Analysis

                16.2.3.4. Strategic Overview

            16.2.4. Merck KGaA

                16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.4.2. Product Portfolio

                16.2.4.3. SWOT Analysis

                16.2.4.4. Strategic Overview

            16.2.5. Cytiva

                16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.5.2. Product Portfolio

                16.2.5.3. SWOT Analysis

                16.2.5.4. Strategic Overview

            16.2.6. Agilent Technologies, Inc.

                16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.6.2. Product Portfolio

                16.2.6.3. SWOT Analysis

                16.2.6.4. Strategic Overview

            16.2.7. Avantor, Inc.

                16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.7.2. Product Portfolio

                16.2.7.3. SWOT Analysis

                16.2.7.4. Strategic Overview

            16.2.8. FUJIFILM Irvine Scientific.

                16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.8.2. Product Portfolio

                16.2.8.3. SWOT Analysis

                16.2.8.4. Strategic Overview

            16.2.9. BioLifeSolutions Inc.

                16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.9.2. Product Portfolio

                16.2.9.3. SWOT Analysis

                16.2.9.4. Strategic Overview

            16.2.10. AMSBIO

                16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.10.2. Product Portfolio

                16.2.10.3. SWOT Analysis

                16.2.10.4. Strategic Overview

            16.2.11. Princeton CryoTech

                16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.11.2. Product Portfolio

                16.2.11.3. SWOT Analysis

                16.2.11.4. Strategic Overview

            16.2.12. STEMCELL Technologies Inc.

                16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.12.2. Product Portfolio

                16.2.12.3. SWOT Analysis

                16.2.12.4. Strategic Overview

            16.2.13. LGC SeraCare

                16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.13.2. Product Portfolio

                16.2.13.3. SWOT Analysis

                16.2.13.4. Strategic Overview

            16.2.14. Corning Incorporated

                16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.14.2. Product Portfolio

                16.2.14.3. SWOT Analysis

                16.2.14.4. Strategic Overview

            16.2.15. CellGenix GmbH

                16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.15.2. Product Portfolio

                16.2.15.3. SWOT Analysis

                16.2.15.4. Strategic Overview

            16.2.16. Others

                16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.16.2. Product Portfolio

                16.2.16.3. SWOT Analysis

                16.2.16.4. Strategic Overview

    List of Tables

    Table 01: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 02: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

    Table 03: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

    Table 04: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 05: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 06: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

    Table 07: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

    Table 08: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 10: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 11: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 12: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

    Table 13: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

    Table 14: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 15: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 16: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

    Table 17: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

    Table 18: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 19: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 20: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 21: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

    Table 22: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

    Table 23: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 25: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

    Table 26: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

    Table 27: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 28: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 29: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 30: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

    Table 31: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

    Table 32: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 33: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 34: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

    Table 35: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

    Table 36: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 37: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 38: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 39: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

    Table 40: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

    Table 41: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 42: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 43: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

    Table 44: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

    Table 45: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 46: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 47: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 48: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Cells, 2017–2031

    Table 49: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Tissues, 2017–2031

    Table 50: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 51: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 52: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

    Table 53: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by Bio preservation media, 2017–2031

    Table 54: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Cell & Tissue Preservation Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Cell & Tissue Preservation Market Value Share, by Type, 2020

    Figure 03: Global Cell & Tissue Preservation Market Value Share, by Product, 2020

    Figure 04: Global Cell & Tissue Preservation Market Value Share, by Application, 2020

    Figure 05: Global Cell & Tissue Preservation Market Value Share, by Region, 2020

    Figure 06: Global Cell & Tissue Preservation Market Value Share, by End-user, 2020

    Figure 07: Global Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

    Figure 08: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

    Figure 09: Global Cell & Tissue Preservation Market Value (US$ Mn), by Cells, 2017–2031

    Figure 10: Global Cell & Tissue Preservation Market Value (US$ Mn), by Tissues, 2017–2031

    Figure 11: Global Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

    Figure 12: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

    Figure 13: Global Cell & Tissue Preservation Market Value (US$ Mn), by Therapeutics, 2017–2031

    Figure 14: Global Cell & Tissue Preservation Market Value (US$ Mn), by Research & Development, 2017–2031

    Figure 15: Global Cell & Tissue Preservation Market Value (US$ Mn), by Drug Discovery, 2017–2031

    Figure 16: Global Cell & Tissue Preservation Market Value (US$ Mn), by Others (Cosmetics and Clinical trials), 2017–2031

    Figure 17: Global Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

    Figure 18: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

    Figure 19: Global Cell & Tissue Preservation Market Value (US$ Mn), by Equipment, 2017–2031

    Figure 20: Global Cell & Tissue Preservation Market Value (US$ Mn), by Bio Preservation Media, 2017–2031

    Figure 21: Global Cell & Tissue Preservation Market Value (US$ Mn), by Software, 2017–2031

    Figure 22: Global Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 23: Global Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 24: Global Cell & Tissue Preservation Market Value (US$ Mn), by Biobanks, 2017–2031

    Figure 25: Global Cell & Tissue Preservation Market Value (US$ Mn), by Hospitals, 2017–2031

    Figure 26: Global Cell & Tissue Preservation Market Value (US$ Mn), by Others, 2017–2031

    Figure 27: Global Cell & Tissue Preservation Market Value Share Analysis, by Region, 2020 and 2031

    Figure 28: Global Cell & Tissue Preservation Market Attractiveness Analysis, by Region, 2021–2031

    Figure 29: North America Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 30: North America Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031

    Figure 31: North America Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031

    Figure 32: North America Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

    Figure 33: North America Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

    Figure 34: North America Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

    Figure 35: North America Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

    Figure 36: North America Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

    Figure 37: North America Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

    Figure 38: North America Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 39: North America Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 40: Europe Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 41: Europe Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031

    Figure 42: Europe Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031

    Figure 43: Europe Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

    Figure 44: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

    Figure 45: Europe Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

    Figure 46: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

    Figure 47: Europe Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

    Figure 48: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

    Figure 49: Europe Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 50: Europe Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 51: Asia Pacific Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 52: Asia Pacific Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031

    Figure 53: Asia Pacific Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031

    Figure 54: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

    Figure 55: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

    Figure 56: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

    Figure 57: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

    Figure 58: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

    Figure 59: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

    Figure 60: Asia Pacific Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 61: Asia Pacific Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 62: Latin America Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 63: Latin America Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031

    Figure 64: Latin America Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031

    Figure 65: Latin America Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

    Figure 66: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

    Figure 67: Latin America Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

    Figure 68: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

    Figure 69: Latin America Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

    Figure 70: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

    Figure 71: Latin America Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 72: Latin America Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 73: Middle East & Africa Cell & Tissue Preservation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 74: Middle East & Africa Cell & Tissue Preservation Market Value Share, by Country/Sub-region, 2020–2031

    Figure 75: Middle East & Africa Cell & Tissue Preservation Market Attractiveness, by Country/Sub-region, 2021–2031

    Figure 76: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by Type, 2020 and 2031

    Figure 77: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by Type, 2021–2031

    Figure 78: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by Application, 2020 and 2031

    Figure 79: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by Application, 2021–2031

    Figure 80: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by Product, 2020 and 2031

    Figure 81: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by Product, 2021–2031

    Figure 82: Middle East & Africa Cell & Tissue Preservation Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 83: Middle East & Africa Cell & Tissue Preservation Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 84: Global Cell & Tissue Preservation Market Share, by Company, 2020

Copyright © Transparency Market Research, Inc. All Rights reserved